Evaluation of the use of Botulinum Toxin as an Alternative tothe use of the Occlusal Splint in the Treatment of Patients withBruxism Systematic Review of the Literature

  1. Paula Sanz Sánchez 1
  2. Ángela Sanz Sánchez 1
  3. Beatriz Pardal-Peláez 1
  4. Daniel Sarmiento Govea 1
  5. Cristina Gómez Polo 1
  6. Javier Flores Fraile 1
  1. 1 Universidad de Salamanca
    info

    Universidad de Salamanca

    Salamanca, España

    ROR https://ror.org/02f40zc51

Revista:
International Journal of Dentistry and Oral Health

ISSN: 2471-657X

Ano de publicación: 2023

Volume: 9

Número: 3

Páxinas: 1-7

Tipo: Artigo

GOOGLE SCHOLAR

Outras publicacións en: International Journal of Dentistry and Oral Health

Resumo

Bruxism is a parafunctional habit based on rhythmic mandibular movements which can occurduring sleep and/or wakefulness, often leading to myofascial pain symptoms. The usual treatment is byocclusal splint. To identify the symptoms reported by bruxism patients and to compare the efficacy oftreatment with botulinum toxin against treatment with occlusal splint. A systematic review of randomizedclinical trials which measure the objective and subjective effects on the masseter and/or temporalis ofbotulinum toxin versus an occlusal splint. Both botulinum toxin and occlusal splint were found to reducepain to the same degree. The toxin is able to reduce contractile intensity of the muscles in the first 2-6weeks of application. These treatments do not affect the development or origin of episodes of bruxism.From these results, low doses of botulinum toxin can be a therapeutic alternative for patients with eitherlow responsiveness to occlusal splints or in whom the use of a splint is contraindicated.

Referencias bibliográficas

  • 1] Jadhao VA, Lokhande N, Habbu SG, Sewane S, Dongare S, Goyal N. Efficacy of botulinum toxin in treating [myofascial pain and occlusal force characteristics of masticatory muscles in bruxism. Indian J Dent Res . 2017 ;28(5):493-497.
  • [2] Shim YJ, Lee HJ, Park KJ, Kim HT, Hong IH, Kim ST. Botulinum Toxin Therapy for Managing Sleep Bruxism: A Randomized and Placebo-Controlled Trial. Toxins (Basel). 2020 ;12(3):168.
  • [3] Ondo WG, Simmons JH, Shahid MH, Hashem V, Hunter C, Jankovic J. Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study. Neurology. 2018 ;90(7):e559-e564.
  • [4] Bergmann A, Edelhoff D, Schubert O, Erdelt KJ, Pho Duc JM. Effect of treatment with a full-occlusion biofeedback splint on sleep bruxism and TMD pain: a randomized controlled clinical trial. Clinical Oral Research . 2020 ;24(11):4005-4018.
  • [5] Keskinruzgar A, Kucuk AO, Yavuz GY, Koparal M, Caliskan ZG, Utkun M. Comparison of kinesio taping and occlusal splint in the management of myofascial pain in patients with sleep bruxism. J Back Musculoskelet Rehab . 2019 ;32(1):1-6.
  • [6] Gerstner G, Yao W, Siripurapu K, Aljanabi H, Decker A, Ludkin D, Sinacola R, Frimenko K, Callaghan K, Penoyer S, Tewksbury C. Over-the-counter bite splints: A randomized controlled trial of compliance and efficacy. Clin Exp Dent Res. 2020 ;6(6):626-641.
  • [7] Matsumoto H, Tsukiyama Y, Kuwatsuru R, Koyano K. The effect of intermittent use of occlusal splint devices on sleep bruxism: a 4-week observation with a portable electromyographic recording device. J Oral Rehabilitation . 2015 ;42(4):251-8.
  • [8] Kaya DI, Ataoglu H. Botulinum toxin treatment of temporomandibular joint pain in patients with bruxism: A prospective and randomized clinical study . Niger J Clin Pract . 2021 ;24(3):412-417.
  • [9] İspirgil E PhD, Erdoğan SB PhD, Akın A PhD, Şakar O PhD. The hemodynamic effects of occlusal splint therapy on the masseter muscle of patients with myofascial pain accompanied by bruxism. Cranium . 2020 ;38(2):99-108.
  • [10] Dalewski B, Chruściel-Nogalska M, Frączak B. Occlusal splint versus modified nociceptive trigeminal inhibition splint in bruxism therapy: a randomized, controlled trial using surface electromyography. Austin Dent J. 2015 ;60(4):445-54.
  • [11] Singh PK, Alvi HA, Singh BP, Singh RD, Kant S, Jurel S, Singh K, Arya D, Dubey A. Evaluation of various treatment modalities in sleep bruxism. J Prosthet Dent . 2015 ;114(3):426-31.
  • [12] Yin XM, Zhang JL, Zhang DZ, Yao ZX. [A study of electrical information monitoring in the treatment of bruxism with occlusal splint]. Zhonghua Kou Qiang Yi Xue Za Zhi . Chinese. 2004 ;39(3):245-7.
  • [13] Lee SJ, McCall WD Jr, Kim YK, Chung SC, Chung JW. Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial. Am J Phys Med Rehabil . 2010 ;89(1):16-23.
  • [14] Zhang LD, Liu Q, Zou DR, Yu LF. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX - A) for treatment of temporomandibular disorder. Br J Oral Maxillofac Surg. 2016 ;54(7):736-40.
  • [15] Shim YJ, Lee MK, Kato T, Park HU, Heo K, Kim ST. Effects of botulinum toxin on jaw motor events during sleep in sleep bruxism patients: a polysomnographic evaluation. J Clin Sleep Med. 2014 ;10(3):291-8.
  • [16] Conti PC, Corrêa AS, Lauris JR, Stuginski ‐Barbosa J. Management of painful temporomandibular joint clicking with different intraoral devices and counseling: A controlled study. J Appl Oral Sci 2015 ; 23:529-35.
  • [17] Yurttutan ME, Tu ̈ tu ̈ ncu ̈ ler Sancak K , Tü zu ̈ner AM . Which treatment is effective for bruxism: Occlusal splints or botulinum toxin?. J Oral Maxillofac Surg. 2019 ; 77:2431-8.
  • [18] Ahn BK, Kim YS, Kim HJ, Rho NK, Kim HS. Consensus recommendations on the aesthetic usage of botulinum toxin type A in Asians. Dermatol Surg . 2013 ; 39:1843-60.
  • [19] Delcanho R, Val M, Nardini LG, Manfredini D. Botulinum Toxin for Treating Temporomandibular Disorders: What is the Evidence? J Oral Facial Pain Headache. 2022 Winter;36(1):6-20.
  • [20] Pardo NB, Kerstein RB, Júnior MC, Ferreira LS, Abrahão M. Botulinum toxin type A for controlling bruxism assessed with computerized occlusal analysis: A pilot study. Cranio2022 May;40(3):207-216.